Article Details
Retrieved on: 2018-02-24 00:30:00
Tags for this article:
Click the tags to see associated articles and topics
Excerpt
<div><b>Vanguard Group</b> Inc. raised its position in shares of Adamis Pharmaceuticals by 22.2% in the second quarter. <b>Vanguard Group</b> Inc. now owns 942,940 shares of the specialty pharmaceutical company's stock worth $4,903,000 after acquiring an additional 171,167 shares during the period. Finally, EAM ...</div>
Article found on:
This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.
Sign UpAlready have an account? Log in here